نتایج جستجو برای: aldose reductase inhibitors

تعداد نتایج: 226836  

Journal: :medical journal of islamic republic of iran 0
amir-hamzeh pordal faculty of nutrition and food technology, shahidbeheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) seyed javad hajmiresmail department of cardiology, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) mohammad assadpoor-piranfar department of cardiology, taleghani hospital, school of medicine, shahid beheshti university of medical sciences, tehran. iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) mehdi hedayati head of cellular and molecular research center, research institute for endocrine sciences, shahid beheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences) marjan ajami department of food and nutrition policy and planning research, national nutrition and food technology research institute, faculty of nutrition and food technology, shahidbeheshti university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید بهشتی (shahid beheshti university of medical sciences)

background: considering the increasing incidence of coronary artery stenosis and its related complications, the importance of its etiology and inconsistent reports we aimed to determine the relationship between oxysterol, serum levels and severity of coronary atherosclerosis and effect of statins on oxysterol.  methods: a total of 85 patients referred to taleghani hospital, tehran, iran during ...

2014
Xin Hu Shengbing Li Gangyi Yang Hua Liu Guenther Boden Ling Li

BACKGROUND Aldose reductase inhibitors (ARIs) can block the metabolism of the polyol pathway, and have been used to slow or reverse the progression of diabetic cardiovascular autonomic neuropathy (DCAN). The purpose of this study was to review the effectiveness and safety of ARIs in the treatment of DCAN as determined by five cardiac autonomic neuropathy function tests. METHODS CENTRAL, MEDLI...

Journal: :Open journal of nephrology 2012
William Brian Reeves Bishal B Rawal Emaad M Abdel-Rahman Alaa S Awad

Diabetes mellitus is the leading cause of end stage renal disease and is responsible for more than 40% of all cases in the United States. Several therapeutic interventions for the treatment of diabetic nephropathy have been developed and implemented over the past few decades with some degree of success. However, the renal protection provided by these therapeutic modalities is incomplete. More e...

2012
Sivasubramanian Suhitha Krishnaswamy Gunasekaran Devadasan Velmurugan

Medicinal plants and marine sources are important elements of indigenous medical systems worldwide. The natural drugs from medicinal plants and marine sources have received considerable interest in treatment of diabetes and inflammation. Based on literature, alpha glucosidase, aldose reductase and PTP1B enzymes were chosen as anti-diabetes targets and PLA(2) was chosen for the anti-inflammatory...

Journal: :The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1994
A A Sima

Diabetic neuropathy is a major complication of diabetes mellitus affecting to an equal extent type 1 and type 2 patients. Various mechanisms including metabolic and vascular abnormalities have been proposed to explain the progressive pathological changes that occur in peripheral nerve. Regardless of the precise mechanisms, structural abnormalities lead to functional changes which eventually res...

Journal: :Investigative ophthalmology & visual science 1982
M Datiles H Fukui T Kuwabara J H Kinoshita

Cataract formation in galactosemic rats was studied by ophthalmoscopy, slit-lamp biomicroscopy, and by light microscopy using plastic embedding with methacrylate. Untreated rats developed nuclear cataracts by 14 days and mature cataracts by 21 days. However, rats treated with the aldose reductase inhibitor sorbinil did not develop any cataractous change for up to 8 months of 50% galactose feedi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید